Sleep deficits but no metabolic deficits in premanifest Huntington's disease
Open Access
- 21 August 2015
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 78 (4) , 630-648
Abstract
Objective: Huntington disease (HD) is a fatal autosomal dominant, neurodegenerative condition characterized by progressively worsening motor and nonmotor problems including cognitive and neuropsychiatric disturbances, along with sleep abnormalities and weight loss. However, it is not known whether sleep disturbances and metabolic abnormalities underlying the weight loss are present at a premanifest stage.Methods: We performed a comprehensive sleep and metabolic study in 38 premanifest gene carrier individuals and 36 age‐ and sex‐matched controls. The study consisted of 2 weeks of actigraphy at home, 2 nights of polysomnography and multiple sleep latency tests in the laboratory, and body composition assessment using dual energy x‐ray absorptiometry scanning with energy expenditure measured over 10 days at home by doubly labeled water and for 36 hours in the laboratory by indirect calorimetry along with detailed cognitive and clinical assessments. We performed a principal component analyses across all measures within each studied domain.Results: Compared to controls, premanifest gene carriers had more disrupted sleep, which was best characterized by a fragmented sleep profile. These abnormalities, as well as a theta power (4–7Hz) decrease in rapid eye movement sleep, were associated with disease burden score. Objectively measured sleep problems coincided with the development of cognitive, affective, and subtle motor deficits and were not associated with any metabolic alterations.Interpretation: The results show that among the earliest abnormalities in premanifest HD is sleep disturbances. This raises questions as to where the pathology in HD begins and also whether it could drive some of the early features and even possibly the pathology. Ann Neurol 2015;78:630–648Keywords
Funding Information
- National Institute for Health Research (CHDI-RG50786, BRC-RG64473)
- Medical Research Council Program (MC_UP_A090_1005)
This publication has 66 references indexed in Scilit:
- β Oscillation during Slow Wave Sleep and Rapid Eye Movement Sleep in the Electroencephalogram of a Transgenic Mouse Model of Huntington’s DiseasePLOS ONE, 2013
- The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and SleepPLOS ONE, 2013
- Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington’s diseaseBrain, 2013
- Progressive sleep and electroencephalogram changes in mice carrying the Huntington’s disease mutationBrain, 2013
- Huntington's disease: from molecular pathogenesis to clinical treatmentThe Lancet Neurology, 2011
- Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease ProgressionPLOS ONE, 2007
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- Factor structure of the barratt impulsiveness scaleJournal of Clinical Psychology, 1995
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979